IMR Press / FBL / Volume 10 / Issue 1 / DOI: 10.2741/1551

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Brain chemotherapy from the bench to the clinic: targeting neuronal survival with small molecule inhibitors of apoptosis
Show Less
1 The Molecular and Cell Biology Department, FO 3.1, The University of Texas at Dallas, P.O. Box 830688, Richardson, Texas 75083-0688, USA
Front. Biosci. (Landmark Ed) 2005, 10(1), 552–568; https://doi.org/10.2741/1551
Published: 1 January 2005
Abstract

Increasing evidence implicates aberrant apoptosis as a fundamental cause of neurodegenerative diseases. Thus elucidating the underlying causes of neuronal programmed cell death may foster the development of therapeutic interventions. Research in the last 15 years provided a solid foundation for understanding molecular mechanisms of neuronal apoptosis. This review discusses the major molecules and signaling pathways leading to neuronal survival or apoptosis with emphasis on several small molecule inhibitors that target neuronal survival with the hope of impeding the detrimental effects of neurodegenerative diseases.

Keywords
Neuron
Neurodegenerative Disease
Neurodegeneration
GW5074
CEP-1347
Review
Share
Back to top